

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.55219521 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.01447906 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.01174690 |
| 4 | vocalization behavior (GO:0071625) | 4.99436193 |
| 5 | synaptic vesicle maturation (GO:0016188) | 4.78396288 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.75563551 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.72388712 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.61776991 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.59080485 |
| 10 | glutamate secretion (GO:0014047) | 4.55422482 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.45563400 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.40859602 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.23544415 |
| 14 | regulation of synapse structural plasticity (GO:0051823) | 4.06414193 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.04980641 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.03700584 |
| 17 | protein localization to synapse (GO:0035418) | 3.98487812 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 3.95972306 |
| 19 | exploration behavior (GO:0035640) | 3.95530852 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.95243655 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.88336767 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 3.87933892 |
| 23 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.83811789 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 3.83703074 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 3.83297721 |
| 26 | layer formation in cerebral cortex (GO:0021819) | 3.78098012 |
| 27 | behavioral response to nicotine (GO:0035095) | 3.74596708 |
| 28 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.66028947 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 3.62781251 |
| 30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.59829955 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.57414928 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 3.51130753 |
| 33 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.50217735 |
| 34 | neuronal action potential propagation (GO:0019227) | 3.49821186 |
| 35 | cell migration in hindbrain (GO:0021535) | 3.49351564 |
| 36 | proline transport (GO:0015824) | 3.49345048 |
| 37 | gamma-aminobutyric acid transport (GO:0015812) | 3.48069400 |
| 38 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.44252474 |
| 39 | presynaptic membrane assembly (GO:0097105) | 3.41573298 |
| 40 | regulation of postsynaptic membrane potential (GO:0060078) | 3.40748130 |
| 41 | neuron recognition (GO:0008038) | 3.36559908 |
| 42 | presynaptic membrane organization (GO:0097090) | 3.35863595 |
| 43 | prepulse inhibition (GO:0060134) | 3.33247212 |
| 44 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.33051708 |
| 45 | dendritic spine morphogenesis (GO:0060997) | 3.31680963 |
| 46 | long-term memory (GO:0007616) | 3.31155531 |
| 47 | dendrite morphogenesis (GO:0048813) | 3.29949512 |
| 48 | negative regulation of dendrite development (GO:2000171) | 3.28769351 |
| 49 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.28118283 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 3.28034820 |
| 51 | regulation of synapse maturation (GO:0090128) | 3.27175928 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.25953752 |
| 53 | regulation of synaptic plasticity (GO:0048167) | 3.24853770 |
| 54 | behavioral defense response (GO:0002209) | 3.23918767 |
| 55 | behavioral fear response (GO:0001662) | 3.23918767 |
| 56 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.23064220 |
| 57 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.21582766 |
| 58 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.21509136 |
| 59 | neuromuscular process controlling balance (GO:0050885) | 3.18670195 |
| 60 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.17700708 |
| 61 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.16767017 |
| 62 | axonal fasciculation (GO:0007413) | 3.14320033 |
| 63 | membrane depolarization during action potential (GO:0086010) | 3.13745834 |
| 64 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.13025440 |
| 65 | activation of protein kinase A activity (GO:0034199) | 3.12560879 |
| 66 | innervation (GO:0060384) | 3.08969641 |
| 67 | nucleobase catabolic process (GO:0046113) | 3.08690290 |
| 68 | sodium ion export (GO:0071436) | 3.08524624 |
| 69 | cell communication by electrical coupling (GO:0010644) | 3.07971530 |
| 70 | synapse assembly (GO:0007416) | 3.06983627 |
| 71 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.04320464 |
| 72 | neurotransmitter transport (GO:0006836) | 3.04067647 |
| 73 | dopamine receptor signaling pathway (GO:0007212) | 3.01365810 |
| 74 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.01030270 |
| 75 | membrane hyperpolarization (GO:0060081) | 3.00803113 |
| 76 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.99871528 |
| 77 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.99871528 |
| 78 | membrane depolarization (GO:0051899) | 2.98083810 |
| 79 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.97619957 |
| 80 | cell proliferation in forebrain (GO:0021846) | 2.97109317 |
| 81 | regulation of vesicle fusion (GO:0031338) | 2.96581404 |
| 82 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.95500251 |
| 83 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.94915175 |
| 84 | response to histamine (GO:0034776) | 2.93310024 |
| 85 | membrane repolarization during action potential (GO:0086011) | 2.92021251 |
| 86 | fear response (GO:0042596) | 2.91565633 |
| 87 | synaptic vesicle endocytosis (GO:0048488) | 2.91242920 |
| 88 | regulation of neurotransmitter secretion (GO:0046928) | 2.91194325 |
| 89 | limb bud formation (GO:0060174) | 2.90708501 |
| 90 | regulation of neurotransmitter levels (GO:0001505) | 2.88866795 |
| 91 | long-term synaptic potentiation (GO:0060291) | 2.87041740 |
| 92 | regulation of dendritic spine development (GO:0060998) | 2.86147549 |
| 93 | auditory behavior (GO:0031223) | 2.83630751 |
| 94 | striatum development (GO:0021756) | 2.82564146 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 2.82511360 |
| 96 | positive regulation of fibroblast migration (GO:0010763) | 2.81868073 |
| 97 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.80576783 |
| 98 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79117080 |
| 99 | transmission of nerve impulse (GO:0019226) | 2.78727067 |
| 100 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.76300375 |
| 101 | regulation of neurotransmitter transport (GO:0051588) | 2.76218505 |
| 102 | neuromuscular process (GO:0050905) | 2.76029682 |
| 103 | spinal cord development (GO:0021510) | 2.75948973 |
| 104 | vesicle transport along microtubule (GO:0047496) | 2.75788506 |
| 105 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.75406678 |
| 106 | behavioral response to cocaine (GO:0048148) | 2.74598145 |
| 107 | cerebellar granule cell differentiation (GO:0021707) | 2.73244326 |
| 108 | postsynaptic membrane organization (GO:0001941) | 2.71379015 |
| 109 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.71034714 |
| 110 | learning (GO:0007612) | 2.68221693 |
| 111 | neuronal action potential (GO:0019228) | 2.67383757 |
| 112 | artery development (GO:0060840) | 2.66957297 |
| 113 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.66532500 |
| 114 | response to auditory stimulus (GO:0010996) | 2.66022100 |
| 115 | establishment of nucleus localization (GO:0040023) | 2.64742328 |
| 116 | regulation of female receptivity (GO:0045924) | 2.64484474 |
| 117 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.62486069 |
| 118 | retinal ganglion cell axon guidance (GO:0031290) | 2.57542672 |
| 119 | neurofilament cytoskeleton organization (GO:0060052) | 2.55689050 |
| 120 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.55270875 |
| 121 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.53470392 |
| 122 | cerebral cortex cell migration (GO:0021795) | 2.52202150 |
| 123 | negative regulation of astrocyte differentiation (GO:0048712) | 2.51855273 |
| 124 | axon ensheathment in central nervous system (GO:0032291) | 2.51142726 |
| 125 | central nervous system myelination (GO:0022010) | 2.51142726 |
| 126 | membrane repolarization (GO:0086009) | 2.49383112 |
| 127 | serotonin metabolic process (GO:0042428) | 2.43777813 |
| 128 | positive regulation of action potential (GO:0045760) | 2.42566053 |
| 129 | axon extension (GO:0048675) | 2.40521370 |
| 130 | regulation of hippo signaling (GO:0035330) | 2.39672762 |
| 131 | synapse organization (GO:0050808) | 2.37049080 |
| 132 | positive regulation of synapse assembly (GO:0051965) | 2.36568805 |
| 133 | primary amino compound metabolic process (GO:1901160) | 2.35277449 |
| 134 | multicellular organismal signaling (GO:0035637) | 2.35264926 |
| 135 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.32950670 |
| 136 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.30029215 |
| 137 | forebrain neuron differentiation (GO:0021879) | 2.28251096 |
| 138 | establishment of mitochondrion localization (GO:0051654) | 2.26912186 |
| 139 | adult walking behavior (GO:0007628) | 2.26074435 |
| 140 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.24459964 |
| 141 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.23296891 |
| 142 | neuromuscular synaptic transmission (GO:0007274) | 2.22933884 |
| 143 | somite development (GO:0061053) | 2.22596336 |
| 144 | positive regulation of dendritic spine development (GO:0060999) | 2.22248372 |
| 145 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.21421666 |
| 146 | parturition (GO:0007567) | 2.20331622 |
| 147 | camera-type eye morphogenesis (GO:0048593) | 2.19208848 |
| 148 | mechanosensory behavior (GO:0007638) | 2.19109963 |
| 149 | cellular anion homeostasis (GO:0030002) | 2.18424466 |
| 150 | peristalsis (GO:0030432) | 2.17841465 |
| 151 | C4-dicarboxylate transport (GO:0015740) | 2.17386289 |
| 152 | regulation of synapse assembly (GO:0051963) | 2.17339593 |
| 153 | dendrite development (GO:0016358) | 2.16401239 |
| 154 | forebrain cell migration (GO:0021885) | 2.14726208 |
| 155 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.14683474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.42689540 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.34189499 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.77136228 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.71742448 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.62593254 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46304219 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46304219 |
| 8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.43862736 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37620083 |
| 10 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.36708533 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.34496397 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.30485156 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.28911286 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26517473 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.20088920 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18432343 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.17124363 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.13643127 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99623383 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97727576 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.95869760 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.94896595 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.91756115 |
| 24 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.91320967 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81614447 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.78605440 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76962380 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.73898849 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73491841 |
| 30 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69025094 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.68874761 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67405635 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60085808 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56504364 |
| 35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.54813821 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52916125 |
| 37 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48040623 |
| 38 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.47124000 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45172672 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45151922 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43978484 |
| 42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42077338 |
| 43 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40001278 |
| 44 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36426424 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35208552 |
| 46 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33029249 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32624317 |
| 48 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.32275679 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31966424 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31257029 |
| 51 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31036710 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29085697 |
| 53 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28601166 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28118170 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26791585 |
| 56 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25064532 |
| 57 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24397928 |
| 58 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.24032395 |
| 59 | * AR_19668381_ChIP-Seq_PC3_Human | 1.23486533 |
| 60 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23019022 |
| 61 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22864440 |
| 62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.21182990 |
| 63 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21130098 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19454804 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18780362 |
| 66 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17739046 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17224054 |
| 68 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17207135 |
| 69 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16778182 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15243798 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14742433 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14118159 |
| 73 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14043640 |
| 74 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12914875 |
| 75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12556944 |
| 76 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12047095 |
| 77 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11964415 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11354498 |
| 79 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10439332 |
| 80 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09679640 |
| 81 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.09324917 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08502747 |
| 83 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06865567 |
| 84 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.06856101 |
| 85 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06702203 |
| 86 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05182148 |
| 87 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04006483 |
| 88 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04006483 |
| 89 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.03271398 |
| 90 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03076761 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03040706 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02033378 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01947385 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01555057 |
| 95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00855486 |
| 96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00819749 |
| 97 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.00344505 |
| 98 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00083814 |
| 99 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99524374 |
| 100 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99080713 |
| 101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98296738 |
| 102 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97671564 |
| 103 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97594710 |
| 104 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.97000671 |
| 105 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96997841 |
| 106 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96680765 |
| 107 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95696047 |
| 108 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95630619 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94879100 |
| 110 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94577953 |
| 111 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93134106 |
| 112 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92801350 |
| 113 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92702207 |
| 114 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92592285 |
| 115 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92592285 |
| 116 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90370327 |
| 117 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90259808 |
| 118 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.90218645 |
| 119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90094840 |
| 120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89948110 |
| 121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87218577 |
| 122 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86935041 |
| 123 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86872960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.42883121 |
| 2 | MP0003880_abnormal_central_pattern | 4.28106475 |
| 3 | MP0004270_analgesia | 4.07628937 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.86524773 |
| 5 | MP0002822_catalepsy | 3.38213318 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.37649452 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.22925392 |
| 8 | MP0009745_abnormal_behavioral_response | 3.12919108 |
| 9 | MP0002735_abnormal_chemical_nociception | 3.00173661 |
| 10 | MP0002064_seizures | 2.78024400 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.73776584 |
| 12 | MP0006292_abnormal_olfactory_placode | 2.72870119 |
| 13 | MP0002736_abnormal_nociception_after | 2.70215204 |
| 14 | MP0009046_muscle_twitch | 2.69340453 |
| 15 | MP0000566_synostosis | 2.66106248 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.61991656 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.43010766 |
| 18 | MP0002733_abnormal_thermal_nociception | 2.28368687 |
| 19 | MP0002272_abnormal_nervous_system | 2.25332049 |
| 20 | MP0001486_abnormal_startle_reflex | 2.24533477 |
| 21 | MP0004858_abnormal_nervous_system | 2.12343520 |
| 22 | MP0001970_abnormal_pain_threshold | 2.04204954 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.00179315 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.97516736 |
| 25 | MP0002184_abnormal_innervation | 1.90428540 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.89802963 |
| 27 | MP0000778_abnormal_nervous_system | 1.86111006 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.85669400 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.85611433 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.83147674 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.75825738 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.71552542 |
| 33 | MP0003329_amyloid_beta_deposits | 1.71284967 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.67494519 |
| 35 | MP0004924_abnormal_behavior | 1.67494519 |
| 36 | MP0003890_abnormal_embryonic-extraembry | 1.65091187 |
| 37 | MP0001984_abnormal_olfaction | 1.64282281 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.64161003 |
| 39 | MP0003123_paternal_imprinting | 1.62774016 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.62081321 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.61886368 |
| 42 | MP0004885_abnormal_endolymph | 1.51570181 |
| 43 | MP0003879_abnormal_hair_cell | 1.50269896 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.47831771 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.45938175 |
| 46 | MP0003121_genomic_imprinting | 1.45908045 |
| 47 | MP0000955_abnormal_spinal_cord | 1.45584780 |
| 48 | MP0008569_lethality_at_weaning | 1.42451510 |
| 49 | MP0003938_abnormal_ear_development | 1.34396920 |
| 50 | MP0003315_abnormal_perineum_morphology | 1.32926390 |
| 51 | MP0004133_heterotaxia | 1.32065165 |
| 52 | MP0000049_abnormal_middle_ear | 1.30639153 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.30076161 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.28705493 |
| 55 | MP0008789_abnormal_olfactory_epithelium | 1.27009337 |
| 56 | MP0003787_abnormal_imprinting | 1.25205242 |
| 57 | MP0005409_darkened_coat_color | 1.24360888 |
| 58 | MP0003942_abnormal_urinary_system | 1.24079760 |
| 59 | MP0002938_white_spotting | 1.21646255 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.21312321 |
| 61 | MP0009053_abnormal_anal_canal | 1.18097721 |
| 62 | MP0003937_abnormal_limbs/digits/tail_de | 1.14682998 |
| 63 | MP0002160_abnormal_reproductive_system | 1.13993307 |
| 64 | MP0001529_abnormal_vocalization | 1.12621022 |
| 65 | MP0003119_abnormal_digestive_system | 1.12405058 |
| 66 | MP0003011_delayed_dark_adaptation | 1.08325401 |
| 67 | MP0003633_abnormal_nervous_system | 1.06961628 |
| 68 | MP0008961_abnormal_basal_metabolism | 1.06795273 |
| 69 | MP0000026_abnormal_inner_ear | 1.04034403 |
| 70 | MP0001177_atelectasis | 1.03963988 |
| 71 | MP0003755_abnormal_palate_morphology | 1.03859934 |
| 72 | * MP0002069_abnormal_eating/drinking_beha | 1.02104615 |
| 73 | MP0008874_decreased_physiological_sensi | 1.01939556 |
| 74 | MP0002089_abnormal_postnatal_growth/wei | 1.01785437 |
| 75 | MP0002152_abnormal_brain_morphology | 1.00136007 |
| 76 | MP0002102_abnormal_ear_morphology | 0.98326157 |
| 77 | MP0002653_abnormal_ependyma_morphology | 0.95977595 |
| 78 | MP0010386_abnormal_urinary_bladder | 0.93791086 |
| 79 | MP0002233_abnormal_nose_morphology | 0.90389509 |
| 80 | MP0003631_nervous_system_phenotype | 0.90328946 |
| 81 | MP0001905_abnormal_dopamine_level | 0.90292975 |
| 82 | MP0000751_myopathy | 0.89438783 |
| 83 | MP0005360_urolithiasis | 0.89044708 |
| 84 | MP0000604_amyloidosis | 0.88608395 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.88434885 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.86954871 |
| 87 | MP0005195_abnormal_posterior_eye | 0.85640774 |
| 88 | MP0008872_abnormal_physiological_respon | 0.85148444 |
| 89 | MP0003195_calcinosis | 0.84115552 |
| 90 | MP0002139_abnormal_hepatobiliary_system | 0.84104144 |
| 91 | MP0005535_abnormal_body_temperature | 0.83978823 |
| 92 | MP0004510_myositis | 0.83581069 |
| 93 | MP0008877_abnormal_DNA_methylation | 0.83226279 |
| 94 | * MP0004085_abnormal_heartbeat | 0.83071300 |
| 95 | MP0001293_anophthalmia | 0.80849051 |
| 96 | MP0001299_abnormal_eye_distance/ | 0.80282431 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 0.80091421 |
| 98 | MP0002229_neurodegeneration | 0.79595651 |
| 99 | MP0001666_abnormal_nutrient_absorption | 0.77652520 |
| 100 | MP0005645_abnormal_hypothalamus_physiol | 0.76694143 |
| 101 | MP0009250_abnormal_appendicular_skeleto | 0.76475662 |
| 102 | MP0001188_hyperpigmentation | 0.74912541 |
| 103 | MP0002116_abnormal_craniofacial_bone | 0.74381316 |
| 104 | MP0003385_abnormal_body_wall | 0.74284771 |
| 105 | MP0005551_abnormal_eye_electrophysiolog | 0.72406336 |
| 106 | MP0004142_abnormal_muscle_tone | 0.69002321 |
| 107 | MP0005394_taste/olfaction_phenotype | 0.68847146 |
| 108 | MP0005499_abnormal_olfactory_system | 0.68847146 |
| 109 | MP0004484_altered_response_of | 0.68552705 |
| 110 | MP0003075_altered_response_to | 0.67478811 |
| 111 | MP0001664_abnormal_digestion | 0.67305143 |
| 112 | MP0004742_abnormal_vestibular_system | 0.66864646 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.66425088 |
| 114 | MP0003646_muscle_fatigue | 0.64277483 |
| 115 | MP0003122_maternal_imprinting | 0.63075571 |
| 116 | MP0002752_abnormal_somatic_nervous | 0.63043031 |
| 117 | MP0000631_abnormal_neuroendocrine_gland | 0.62263923 |
| 118 | MP0001963_abnormal_hearing_physiology | 0.61603418 |
| 119 | MP0003632_abnormal_nervous_system | 0.60746323 |
| 120 | MP0001485_abnormal_pinna_reflex | 0.58939454 |
| 121 | MP0002090_abnormal_vision | 0.58874736 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.58783529 |
| 123 | MP0010329_abnormal_lipoprotein_level | 0.58189465 |
| 124 | MP0004145_abnormal_muscle_electrophysio | 0.56770064 |
| 125 | MP0003861_abnormal_nervous_system | 0.54253347 |
| 126 | MP0004043_abnormal_pH_regulation | 0.53713052 |
| 127 | MP0005187_abnormal_penis_morphology | 0.53273607 |
| 128 | MP0003634_abnormal_glial_cell | 0.52103782 |
| 129 | MP0005365_abnormal_bile_salt | 0.52093720 |
| 130 | MP0004130_abnormal_muscle_cell | 0.51789422 |
| 131 | MP0001943_abnormal_respiration | 0.51592162 |
| 132 | MP0002638_abnormal_pupillary_reflex | 0.50342308 |
| 133 | MP0005171_absent_coat_pigmentation | 0.50156592 |
| 134 | MP0000534_abnormal_ureter_morphology | 0.50034266 |
| 135 | MP0000013_abnormal_adipose_tissue | 0.49913519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.05133503 |
| 2 | Myokymia (HP:0002411) | 6.75122729 |
| 3 | Focal seizures (HP:0007359) | 5.40896896 |
| 4 | Visual hallucinations (HP:0002367) | 4.39838229 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.04321233 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 3.97614952 |
| 7 | Febrile seizures (HP:0002373) | 3.94728748 |
| 8 | Action tremor (HP:0002345) | 3.88474836 |
| 9 | Abnormality of the lower motor neuron (HP:0002366) | 3.42556807 |
| 10 | Atonic seizures (HP:0010819) | 3.38618226 |
| 11 | Absence seizures (HP:0002121) | 3.36297897 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.27895699 |
| 13 | Hyperventilation (HP:0002883) | 3.25340086 |
| 14 | Dialeptic seizures (HP:0011146) | 3.20646634 |
| 15 | Poor eye contact (HP:0000817) | 3.16536194 |
| 16 | Abnormal social behavior (HP:0012433) | 3.11726750 |
| 17 | Impaired social interactions (HP:0000735) | 3.11726750 |
| 18 | Broad-based gait (HP:0002136) | 3.11657077 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.09872079 |
| 20 | Torticollis (HP:0000473) | 3.07838037 |
| 21 | Amblyopia (HP:0000646) | 2.99423807 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 2.97532515 |
| 23 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.95913111 |
| 24 | Ankle clonus (HP:0011448) | 2.94905352 |
| 25 | Focal dystonia (HP:0004373) | 2.93261813 |
| 26 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.89890478 |
| 27 | Abnormal eating behavior (HP:0100738) | 2.81348463 |
| 28 | Hepatoblastoma (HP:0002884) | 2.80513857 |
| 29 | Dysdiadochokinesis (HP:0002075) | 2.76866454 |
| 30 | Depression (HP:0000716) | 2.72689094 |
| 31 | Epileptiform EEG discharges (HP:0011182) | 2.67507355 |
| 32 | Excessive salivation (HP:0003781) | 2.63342012 |
| 33 | Drooling (HP:0002307) | 2.63342012 |
| 34 | Scanning speech (HP:0002168) | 2.61065727 |
| 35 | Genetic anticipation (HP:0003743) | 2.60036419 |
| 36 | Limb dystonia (HP:0002451) | 2.58703030 |
| 37 | Urinary urgency (HP:0000012) | 2.58315742 |
| 38 | Dysmetria (HP:0001310) | 2.55932692 |
| 39 | Dysmetric saccades (HP:0000641) | 2.55568373 |
| 40 | Anxiety (HP:0000739) | 2.55052941 |
| 41 | EEG with generalized epileptiform discharges (HP:0011198) | 2.54949608 |
| 42 | Abnormality of the nasal septum (HP:0000419) | 2.54678187 |
| 43 | Craniofacial dystonia (HP:0012179) | 2.54315822 |
| 44 | Truncal ataxia (HP:0002078) | 2.49513474 |
| 45 | Ventricular fibrillation (HP:0001663) | 2.49118983 |
| 46 | Osteomalacia (HP:0002749) | 2.48894791 |
| 47 | Failure to thrive in infancy (HP:0001531) | 2.48103753 |
| 48 | Hypsarrhythmia (HP:0002521) | 2.47906744 |
| 49 | Stereotypic behavior (HP:0000733) | 2.46488478 |
| 50 | Termporal pattern (HP:0011008) | 2.45892981 |
| 51 | Insidious onset (HP:0003587) | 2.45892981 |
| 52 | Impaired smooth pursuit (HP:0007772) | 2.43928130 |
| 53 | Shawl scrotum (HP:0000049) | 2.37158541 |
| 54 | Postural instability (HP:0002172) | 2.34390221 |
| 55 | Blue irides (HP:0000635) | 2.30804894 |
| 56 | Fetal akinesia sequence (HP:0001989) | 2.29522142 |
| 57 | Mutism (HP:0002300) | 2.27643668 |
| 58 | Nephronophthisis (HP:0000090) | 2.27194414 |
| 59 | Pheochromocytoma (HP:0002666) | 2.26314711 |
| 60 | True hermaphroditism (HP:0010459) | 2.21148071 |
| 61 | Status epilepticus (HP:0002133) | 2.19587330 |
| 62 | Spastic gait (HP:0002064) | 2.17620684 |
| 63 | Gout (HP:0001997) | 2.17149667 |
| 64 | Short 4th metacarpal (HP:0010044) | 2.15683954 |
| 65 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.15683954 |
| 66 | Impaired vibratory sensation (HP:0002495) | 2.13272562 |
| 67 | Chronic hepatic failure (HP:0100626) | 2.13022594 |
| 68 | Morphological abnormality of the middle ear (HP:0008609) | 2.12543473 |
| 69 | Abnormality of pain sensation (HP:0010832) | 2.11912903 |
| 70 | Impaired pain sensation (HP:0007328) | 2.11912903 |
| 71 | Polyphagia (HP:0002591) | 2.11520951 |
| 72 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.10300984 |
| 73 | Bradykinesia (HP:0002067) | 2.08834381 |
| 74 | Bundle branch block (HP:0011710) | 2.08539928 |
| 75 | Pancreatic cysts (HP:0001737) | 2.08165901 |
| 76 | Oligodontia (HP:0000677) | 2.07728858 |
| 77 | Annular pancreas (HP:0001734) | 2.06367889 |
| 78 | Decreased circulating renin level (HP:0003351) | 2.05718505 |
| 79 | Progressive inability to walk (HP:0002505) | 2.05677457 |
| 80 | Abnormality of the labia minora (HP:0012880) | 2.04539653 |
| 81 | Pancreatic fibrosis (HP:0100732) | 2.04512976 |
| 82 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.04067528 |
| 83 | Gait imbalance (HP:0002141) | 2.03561435 |
| 84 | Fibular aplasia (HP:0002990) | 2.01459900 |
| 85 | Abnormality of the renal medulla (HP:0100957) | 2.00867014 |
| 86 | Obstructive sleep apnea (HP:0002870) | 2.00821812 |
| 87 | Incomplete penetrance (HP:0003829) | 2.00537623 |
| 88 | Lower limb muscle weakness (HP:0007340) | 2.00339963 |
| 89 | Cystic liver disease (HP:0006706) | 1.97812373 |
| 90 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.96060106 |
| 91 | Cutaneous finger syndactyly (HP:0010554) | 1.95710987 |
| 92 | Intention tremor (HP:0002080) | 1.93119814 |
| 93 | Lower limb asymmetry (HP:0100559) | 1.92287172 |
| 94 | Cerebral inclusion bodies (HP:0100314) | 1.91693330 |
| 95 | Pachygyria (HP:0001302) | 1.90870013 |
| 96 | Short femoral neck (HP:0100864) | 1.90414869 |
| 97 | Megalencephaly (HP:0001355) | 1.89293538 |
| 98 | Pointed chin (HP:0000307) | 1.87624709 |
| 99 | Protruding tongue (HP:0010808) | 1.87104922 |
| 100 | Tetraplegia (HP:0002445) | 1.86754233 |
| 101 | Pendular nystagmus (HP:0012043) | 1.85810996 |
| 102 | Absent speech (HP:0001344) | 1.84488680 |
| 103 | Abnormality of midbrain morphology (HP:0002418) | 1.83397468 |
| 104 | Molar tooth sign on MRI (HP:0002419) | 1.83397468 |
| 105 | Papilledema (HP:0001085) | 1.82829069 |
| 106 | Lissencephaly (HP:0001339) | 1.82607580 |
| 107 | Syncope (HP:0001279) | 1.82562559 |
| 108 | Neurofibrillary tangles (HP:0002185) | 1.82207650 |
| 109 | Abnormal EKG (HP:0003115) | 1.82003280 |
| 110 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.81738525 |
| 111 | Optic nerve hypoplasia (HP:0000609) | 1.81001192 |
| 112 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.80882293 |
| 113 | Aplasia involving bones of the extremities (HP:0009825) | 1.79764896 |
| 114 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.79764896 |
| 115 | Aplasia of the phalanges of the hand (HP:0009802) | 1.79764896 |
| 116 | Agitation (HP:0000713) | 1.78736212 |
| 117 | Tented upper lip vermilion (HP:0010804) | 1.78488669 |
| 118 | Generalized myoclonic seizures (HP:0002123) | 1.77166954 |
| 119 | Hemiplegia (HP:0002301) | 1.75107521 |
| 120 | Hemiparesis (HP:0001269) | 1.75086473 |
| 121 | Genital tract atresia (HP:0001827) | 1.74994286 |
| 122 | Vaginal atresia (HP:0000148) | 1.74832331 |
| 123 | Chorioretinal atrophy (HP:0000533) | 1.74010799 |
| 124 | Gait ataxia (HP:0002066) | 1.73950569 |
| 125 | Amyotrophic lateral sclerosis (HP:0007354) | 1.73832805 |
| 126 | Exotropia (HP:0000577) | 1.73458080 |
| 127 | Medial flaring of the eyebrow (HP:0010747) | 1.73259294 |
| 128 | Abnormality of the corticospinal tract (HP:0002492) | 1.73253852 |
| 129 | Prolonged QT interval (HP:0001657) | 1.73142542 |
| 130 | Thyroid-stimulating hormone excess (HP:0002925) | 1.72646741 |
| 131 | Hammertoe (HP:0001765) | 1.71566854 |
| 132 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.71096766 |
| 133 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.69703688 |
| 134 | Short 1st metacarpal (HP:0010034) | 1.69703688 |
| 135 | Clonus (HP:0002169) | 1.68981549 |
| 136 | Metabolic alkalosis (HP:0200114) | 1.67834763 |
| 137 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.67413856 |
| 138 | Hypoplasia of the brainstem (HP:0002365) | 1.67413856 |
| 139 | Neuroendocrine neoplasm (HP:0100634) | 1.66704555 |
| 140 | Hyperactive renin-angiotensin system (HP:0000841) | 1.65182405 |
| 141 | Sleep apnea (HP:0010535) | 1.65125924 |
| 142 | Abnormality of renin-angiotensin system (HP:0000847) | 1.65057873 |
| 143 | Lower limb amyotrophy (HP:0007210) | 1.64885679 |
| 144 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.64402107 |
| 145 | Abnormality of the aortic arch (HP:0012303) | 1.64087992 |
| 146 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.64064611 |
| 147 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.64064611 |
| 148 | Abnormality of saccadic eye movements (HP:0000570) | 1.64020141 |
| 149 | Specific learning disability (HP:0001328) | 1.62675947 |
| 150 | Small hand (HP:0200055) | 1.61903103 |
| 151 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.61240263 |
| 152 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.60049913 |
| 153 | Periauricular skin pits (HP:0100277) | 1.59846549 |
| 154 | Preauricular pit (HP:0004467) | 1.59846549 |
| 155 | Patellar aplasia (HP:0006443) | 1.59208850 |
| 156 | Septo-optic dysplasia (HP:0100842) | 1.57069262 |
| 157 | Hypoplasia of the ulna (HP:0003022) | 1.56622585 |
| 158 | Abnormality of the 4th metacarpal (HP:0010012) | 1.56481125 |
| 159 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.56362452 |
| 160 | Cutaneous syndactyly (HP:0012725) | 1.54850622 |
| 161 | Congenital primary aphakia (HP:0007707) | 1.52878859 |
| 162 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.52727507 |
| 163 | Hyperaldosteronism (HP:0000859) | 1.52682529 |
| 164 | Abnormality of the 1st metacarpal (HP:0010009) | 1.52450131 |
| 165 | Adrenal hypoplasia (HP:0000835) | 1.51951259 |
| 166 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.51396345 |
| 167 | Synostosis of carpal bones (HP:0005048) | 1.51210808 |
| 168 | Postaxial hand polydactyly (HP:0001162) | 1.50200040 |
| 169 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.50018274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.41895091 |
| 2 | NTRK3 | 4.26363844 |
| 3 | MAP3K9 | 4.01782730 |
| 4 | MARK1 | 3.28691216 |
| 5 | DAPK2 | 3.18544619 |
| 6 | MAP3K4 | 3.12260090 |
| 7 | KSR2 | 2.92957532 |
| 8 | MAP2K7 | 2.45179449 |
| 9 | MINK1 | 2.34757974 |
| 10 | KSR1 | 2.11152936 |
| 11 | WNK4 | 2.08773191 |
| 12 | MAP2K4 | 2.00541924 |
| 13 | MAP3K2 | 1.91028765 |
| 14 | PAK6 | 1.90734841 |
| 15 | PRKD3 | 1.83674234 |
| 16 | NTRK2 | 1.71458078 |
| 17 | DAPK1 | 1.70128879 |
| 18 | NTRK1 | 1.65494711 |
| 19 | ARAF | 1.61291430 |
| 20 | RIPK4 | 1.59728285 |
| 21 | EPHB2 | 1.57778433 |
| 22 | CAMKK1 | 1.54806442 |
| 23 | MAP3K12 | 1.51410003 |
| 24 | DYRK2 | 1.51005504 |
| 25 | STK39 | 1.50815285 |
| 26 | CAMK1D | 1.50780180 |
| 27 | MAPK13 | 1.50488416 |
| 28 | CDK5 | 1.41041433 |
| 29 | TAOK1 | 1.39888206 |
| 30 | CASK | 1.36642940 |
| 31 | MAP3K13 | 1.29420305 |
| 32 | SIK2 | 1.28639832 |
| 33 | STK38 | 1.26640803 |
| 34 | LATS2 | 1.23492016 |
| 35 | RET | 1.15624248 |
| 36 | TLK1 | 1.15489313 |
| 37 | PRPF4B | 1.14424565 |
| 38 | GRK5 | 1.13800685 |
| 39 | EPHA2 | 1.10531096 |
| 40 | LMTK2 | 1.09750572 |
| 41 | MAP4K2 | 1.07437246 |
| 42 | ICK | 1.07071724 |
| 43 | BMPR1B | 1.05576380 |
| 44 | TYRO3 | 1.02852566 |
| 45 | PRKCG | 1.02565371 |
| 46 | STK38L | 1.01496492 |
| 47 | RAF1 | 0.99419492 |
| 48 | GRK1 | 0.95639485 |
| 49 | PINK1 | 0.93807825 |
| 50 | CAMK2A | 0.92040200 |
| 51 | PLK2 | 0.90512000 |
| 52 | PTK2B | 0.90411851 |
| 53 | MAP3K6 | 0.90188055 |
| 54 | LATS1 | 0.88276860 |
| 55 | * SGK223 | 0.87147160 |
| 56 | * SGK494 | 0.87147160 |
| 57 | CAMKK2 | 0.85873729 |
| 58 | ADRBK2 | 0.83927870 |
| 59 | ERBB2 | 0.82677392 |
| 60 | BMPR2 | 0.82202606 |
| 61 | MAP2K1 | 0.81106355 |
| 62 | PIK3CA | 0.80976133 |
| 63 | WNK1 | 0.80904381 |
| 64 | * SGK2 | 0.80437012 |
| 65 | SIK3 | 0.79154175 |
| 66 | MAPK15 | 0.78685090 |
| 67 | FER | 0.77972794 |
| 68 | FES | 0.77330254 |
| 69 | MARK2 | 0.76936417 |
| 70 | * SGK3 | 0.76425639 |
| 71 | MAP3K1 | 0.74905482 |
| 72 | CAMK2B | 0.73980645 |
| 73 | CSNK1A1L | 0.73809835 |
| 74 | CDK18 | 0.72196970 |
| 75 | FRK | 0.71078164 |
| 76 | PHKG2 | 0.71036105 |
| 77 | PHKG1 | 0.71036105 |
| 78 | CAMK1 | 0.70979035 |
| 79 | PAK3 | 0.70896288 |
| 80 | AKT3 | 0.70500049 |
| 81 | PKN1 | 0.70411522 |
| 82 | UHMK1 | 0.68286279 |
| 83 | WNK3 | 0.67641335 |
| 84 | PRKCH | 0.66638683 |
| 85 | CDK14 | 0.66626756 |
| 86 | CDK15 | 0.66513964 |
| 87 | BRAF | 0.66035350 |
| 88 | * SGK1 | 0.65861718 |
| 89 | PRKCZ | 0.65838020 |
| 90 | PNCK | 0.65456868 |
| 91 | ACVR1B | 0.62533496 |
| 92 | STK11 | 0.60105941 |
| 93 | TNIK | 0.59552382 |
| 94 | CSNK1E | 0.58175441 |
| 95 | RPS6KA2 | 0.57999223 |
| 96 | CSNK1G2 | 0.56817308 |
| 97 | DYRK3 | 0.56784623 |
| 98 | PDPK1 | 0.55315703 |
| 99 | CSNK1G3 | 0.54392024 |
| 100 | FGFR2 | 0.53865897 |
| 101 | CAMK4 | 0.53856337 |
| 102 | CDK11A | 0.52426637 |
| 103 | OXSR1 | 0.52325327 |
| 104 | PDK1 | 0.52052715 |
| 105 | CSNK1G1 | 0.51137002 |
| 106 | MET | 0.50421051 |
| 107 | NEK1 | 0.48464912 |
| 108 | MKNK2 | 0.46552531 |
| 109 | RPS6KA3 | 0.46431544 |
| 110 | PRKCE | 0.45912114 |
| 111 | CAMK1G | 0.45318126 |
| 112 | DYRK1A | 0.45196490 |
| 113 | ERBB4 | 0.44843883 |
| 114 | MAPKAPK5 | 0.44648516 |
| 115 | DMPK | 0.44205230 |
| 116 | CSNK1A1 | 0.43702530 |
| 117 | * PRKACA | 0.43152932 |
| 118 | MAP3K7 | 0.42958566 |
| 119 | PTK2 | 0.41288814 |
| 120 | PRKAA2 | 0.40204722 |
| 121 | CDC42BPA | 0.39580411 |
| 122 | MOS | 0.39575933 |
| 123 | RIPK1 | 0.38997473 |
| 124 | FGFR1 | 0.37886713 |
| 125 | CAMK2G | 0.37877230 |
| 126 | GSK3B | 0.37743189 |
| 127 | CSNK1D | 0.37043799 |
| 128 | RPS6KB1 | 0.36413506 |
| 129 | MAPK10 | 0.36264131 |
| 130 | BCR | 0.35509595 |
| 131 | INSRR | 0.35403278 |
| 132 | CAMK2D | 0.31607108 |
| 133 | ROCK1 | 0.30409689 |
| 134 | PRKAA1 | 0.29947645 |
| 135 | PRKD2 | 0.29583742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.16688978 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.96051430 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.47085715 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.45928389 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.37165539 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28598030 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.25072936 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.25026214 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.21786657 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14294471 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.07061685 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.99576334 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 1.80815591 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.79633854 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71327104 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.67507304 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.64019910 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.60153341 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.58965989 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.58878072 |
| 21 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.58748644 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.57806395 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55915174 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.49799065 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47685100 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46982843 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.46097436 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.44914162 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.44480354 |
| 30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.42675843 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41408990 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39163692 |
| 33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.38372459 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.36484779 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.34317948 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33004977 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.28691944 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21220873 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.19830527 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16922878 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.16235910 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.14923409 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14143520 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.13322644 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11065109 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09884968 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08108298 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07926729 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07103919 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.07012996 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 1.04983485 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04791253 |
| 53 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.02266342 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01382323 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99721344 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.97862483 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.95906970 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95276331 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93838609 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.93757802 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.92201370 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90090137 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89095648 |
| 64 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.89034431 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88701973 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88229729 |
| 67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88197696 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.87830558 |
| 69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87678752 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.82395871 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81475406 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80031718 |
| 73 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.79944379 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79912828 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78325877 |
| 76 | Tight junction_Homo sapiens_hsa04530 | 0.77924989 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77436037 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77366575 |
| 79 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.77303304 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77180688 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75930990 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75298915 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74963977 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74459973 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72538954 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72261316 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71681025 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71341055 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.71302417 |
| 90 | Protein export_Homo sapiens_hsa03060 | 0.69772955 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69693712 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69412929 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68862108 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68256729 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67322378 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66910881 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66729974 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66298983 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65880915 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65691799 |
| 101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65643982 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64475217 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63800461 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63635969 |
| 105 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63406984 |
| 106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62664803 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61890672 |
| 108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61271789 |
| 109 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60119348 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58883324 |
| 111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58569928 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58277638 |
| 113 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56695387 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55847271 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55798495 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55592431 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55480257 |
| 118 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50621468 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50176382 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.49868209 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49018298 |
| 122 | Adherens junction_Homo sapiens_hsa04520 | 0.48558203 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47566216 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.47544093 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46791332 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46230639 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45112225 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44690939 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44074848 |
| 130 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42439652 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42366719 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40164561 |
| 133 | * Endocytosis_Homo sapiens_hsa04144 | 0.39906430 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35851116 |
| 135 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35459499 |
| 136 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34182380 |
| 137 | Mineral absorption_Homo sapiens_hsa04978 | 0.33528114 |
| 138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31582312 |
| 139 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30610277 |
| 140 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30446992 |
| 141 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.29285631 |
| 142 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28957887 |

